Research Program
Leadership
Helena Hansen, MD, PhD
Cofounder & Director
Landon Pollack
Cofounder & Executive Director
Charles Grob, MD
Cofounder & Clinical Director
Contact Info
https://reconnect.ucla.edu/
760 Westwood Plaza
Los Angeles, CA
ReConnect@ucla.edu
About
The UCLA Psychedelic Studies Initiative is a multidisciplinary program that explores the therapeutic potential of psychedelic compounds for treating mental health conditions. Research areas include depression, anxiety, PTSD, and end-of-life distress. The initiative promotes responsible, ethical research grounded in neuroscience, psychiatry, and cultural understanding. It also supports education and policy development in the emerging field of psychedelic medicine. The goal is to advance scientific knowledge and integrate promising new therapies into clinical care.